Dolder PC
Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
ArticleLSD
Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants.
ArticleLSD
Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.
ArticleLSD
Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis.
ArticleLSD
Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.
ArticleLSD
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.
ArticleLSD
Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers.
ArticlePsilocybin
Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.
ArticlePsilocybin
Motives and Side-Effects of Microdosing With Psychedelics Among Users.
ArticleLSD
Altered network hub connectivity after acute LSD administration.
ArticleLSD
Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects.
ArticleLSD
Alterations of consciousness and mystical-type experiences after acute LSD in humans.
ArticleLSD